Bladder Dysfunction Clinical Trial
Official title:
Impact of Chemotherapy on Urinary Biomarkers and Non-Invasive Urodynamics in Children
The over-arching aim of this study is to evaluate the effects of two specific anti-cancer chemotherapies, vincristine and doxorubicin, on bladder function and urine composition.
Status | Recruiting |
Enrollment | 152 |
Est. completion date | July 9, 2025 |
Est. primary completion date | July 9, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 5 Years to 10 Years |
Eligibility | Inclusion Criteria: - Children aged 5-10 years old - A history of cancer - Treatment with a chemotherapy regimen including VCR and/or DOX - Completion of chemotherapy at least one year prior to study enrollment and survey completion. Exclusion Criteria: - Patients with a: - Primary pelvic tumor - Pelvic irradiation - Pre-existing bladder/bowel dysfunction - Spinal defects - Neurologic disorder - Neuro-oncologic tumor or brain metastasis - Cyclophosphamide or ifosfamide therapy |
Country | Name | City | State |
---|---|---|---|
United States | Children's Hospital Colorado | Aurora | Colorado |
Lead Sponsor | Collaborator |
---|---|
University of Colorado, Denver | Children's Hospital Colorado, National Cancer Institute (NCI), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Proportion of non-normal niUDS patterns between groups | a. Patterns will be scored by blinded reviewers b. Will calculate an Inter-rater Kappa correlation co-efficient i. Utilize consensus review for discrepancies between reviewers and between the patient's 1st/2nd niUDS for the final assignment ii. Will calculate an intra-test reliability (compare correlation between 1st and 2nd patter) c. Chi-square test to compare proportions of non-normal vs. normal pattern type i. Group 1a vs. 2a ii. Group 1b vs. 2b d. Sample Size Calculation: Based on published data of niUDS patterns in children with normal bladder function, we expect 15% of those children in Group 2 to have non-normal niUDS patterns. We hypothesize that 40% of children in Group 1 to have non-normal niUDS patterns. 38 subjects in each gender sub-group provide 80% power to detect this 25% difference with an one-sided chi-square test with an alpha of 0.05. | Immediately after niUDS done at the first visit | |
Primary | Proportion of Elevated Post-Void Residual (PVR) between groups | a. Will use an "average PVR" between the 1st/2nd niUDS for the analysis b. Chi-square test to compare proportions of elevated PVR i. Group 1a vs. 2a ii. Group 1b vs. 2b c. Sample Size Calculation: Based on published data of PVR in children with normal bladder function, we expect 1.5% of those children in Group 2 to have elevated PVR. We hypothesize that 25% of children in Group 1 to have an elevated PVR. 21 subjects in each gender sub-group provide 80% power to detect this 23.5% difference with an one-sided chi-square test with an alpha of 0.05. | 13 months | |
Primary | Compare Peak Flow Rates (Qmax) between groups | a. Will use the average of the two Qmax between the 1st/2nd flow rate for the analysis b. Two group t-test for comparing continuous variables (Qmax) i. Group 1a vs. 2a ii. Group 1b vs. 2b c. Sample Size Calculation: 38 subjects in Group 1a and 2a provide 80% power to detect an effect size of 0.7 (mean difference divided by the common standard deviation) using a 2-sided two-group test with an alpha of 0.05. if the outcome is not normally distributed, transformation will be carried out so the distribution will be approximately normal. This power calculation also applies to the comparison between Group 1b vs 2b | 13 momths | |
Primary | Compare Average Flow Rates (Qavg) for age/gender | a. Will use the average of the two Qavg between the 1st/2nd flow rate for the analysis b. Two group ttest for comparing continuous variables (Qavg) i. Group 1a vs. 2a ii. Group 1b vs. 2b c. See the power calculation in 3c. | 13 months | |
Primary | Compare Urinary Biomarker Levels between groups | 1. Compare urinary biomarker levels between groups i. ATP, BDNF, NGF ii. Two-group t-test for comparing continuous variables
Group 1 vs. 2 Sub-analysis Group 1a vs. 2a Group 1b vs. 2b The sample size calculation in 1d can apply to each biomarker. Based on published data in other populations with BD, for NGF, ATP and BDNF, we hypothesize to detect a difference of these urinary biomarkers 2x higher in Group 2 (Elevated DVSS scores) vs. Group 1 (Normal DVSS scores). A mixed effects model will be used to estimate and compare a biomarker expression between the two groups by incorporating the individual measurements on each subject into the model, where gender and group assignment will be the predictor. Interaction term between group and gender will be considered to study the effect modification by gender on a biomarker if possible. |
13 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT00713921 -
Neuropathic Investigation and Anticholinergic Treatment of Bladder Dysfunction in Diabetes and Stroke Patients
|
Early Phase 1 | |
Withdrawn |
NCT00472784 -
Quantitative and Qualitative Changes in Neural Efferent Receptors
|
||
Completed |
NCT04528784 -
Feasibility Study of Transcutaneous Tibial Nerve Stimulation for Urinary Symptoms in People With Multiple Sclerosis
|
N/A | |
Completed |
NCT02910596 -
Effectiveness of Bethanechol Chloride and Early Bladder Training for Prevention of Bladder Dysfunction After Radical Hysterectomy in Cervical Cancer Stage IB - IIA
|
Phase 4 | |
Terminated |
NCT00688948 -
Alfuzosin for Voiding Dysfunction in Multiple Sclerosis (MS)
|
Phase 2/Phase 3 | |
Completed |
NCT05858840 -
Urinary Artificial Sphincter in Children
|
||
Recruiting |
NCT05968352 -
Restoration of Bladder Function in Spinal Cord Injury
|
||
Recruiting |
NCT05462561 -
Vascularized Composite Bladder Allograft Transplantation
|
N/A | |
Completed |
NCT05013541 -
Effect of Bladder Filling on Rectal Contractions During Cystometry
|
||
Recruiting |
NCT04626167 -
Concomitant Renal and Urinary Bladder Allograft Transplantation
|
Early Phase 1 | |
Completed |
NCT03570593 -
Removal of Urinary Catheter After Radical Surgery
|
N/A | |
Active, not recruiting |
NCT04490642 -
Linguistic Validation of the Childhood Bladder and Bowel Dysfunction Questionnaire (CBBDQ) for 5-12 Years Old in Korean
|
||
Completed |
NCT04057222 -
Effect of Need to Void on Rectal Sensory Function in Multiple Sclerosis
|
||
Not yet recruiting |
NCT06439862 -
Study of the Quality of Life in School Aged-children With Posterior Urethral Valves
|
||
Recruiting |
NCT04835766 -
Urodynamic Changes Following Bladder Injury
|
||
Completed |
NCT05351138 -
Comparison of Transcutaneous Electrical Nerve Stimulation and Manual Therapy in Children With Cerebral Palsy
|
N/A | |
Completed |
NCT03987126 -
Prebiotics for Spinal Cord Injury Patients With Bowel and Bladder Dysfunction
|
Phase 3 | |
Completed |
NCT01460303 -
Patient-operated Valved Catheter Versus Indwelling Transurethral Catheter
|
N/A | |
Completed |
NCT00280592 -
Cranberry for Prevention of Urinary Tract Infections in Multiple Sclerosis Patients
|
Phase 3 | |
Completed |
NCT05861011 -
Bladder Neck Surgery in Children With Neurogenic Bladder
|